Bowen Dong

4PUBLICATIONS
19CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 27, 2026
Split immunomodulatory impact of leptin on human myeloid cells: key role of IDO1 in counteracting the immunostimulatory effect of leptin.

|Jul 01, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.

Bowen Dong, Nataša Obermajer, Takemasa Tsuji

|Oct 27, 2023
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells.

Bowen Dong, Nataša Obermajer, Takemasa Tsuji

|Jan 12, 2021
Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy.

Mark K Farrugia, Mark D Long, David M Mattson

Pageof 1

Frequent Collaborators

2 joint publications

Mark D Long

2 joint publications

Nataša Obermajer

2 joint publications

Scott H Olejniczak

1 joint publications

Mark K Farrugia